OCUL (OCUL) Stock Price & Analysis
OCUL (OCUL) rose 0.00% to USD 10.64 as of September 8, 2026 at 06:55 UTC, according to Nexqual real-time market data.
OCUL last closed at USD 10.64; the session ranged USD 10.51–10.77 on volume of 1,306,871 shares. Market capitalization is —, with a 52-week range of USD 6.23–16.44 (NGM). Source: Nexqual, September 8, 2026 at 06:55 UTC.
Key Statistics (as of September 8, 2026 at 06:55 UTC)
| Price | USD 10.64 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 10.64 |
| Open | USD 10.64 |
| Day Range | USD 10.51 – 10.77 |
| 52-Week Range | USD 6.23 – 16.44 |
| Volume | 1,306,871 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (OCUL)
Nexqual's technical model rates OCUL "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 06:55 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 56.27 (neutral) |
| vs SMA50 | Above (USD 9.76) |
| MACD | 0.33 (positive) |
From OCUL's Latest SEC 10-K Filing (filed 2026-02-05)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc. | USD 1.79 | ▲ 0% |
| OMER | Omeros Corporation | USD 18.95 | ▲ 0.48% |
| EYPT | EyePoint, Inc. | USD 4.58 | ▼ 4.38% |
| PTCT | PTC Therapeutics, Inc. | USD 69.3 | ▼ 3.47% |
| TGTX | TG Therapeutics, Inc. | USD 55.99 | ▼ 1.61% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:55 UTC. This page is informational and not investment advice.